- Home
- NSYS vs ALGS Comparison
NSYS vs ALGS Comparison
Compare NSYS & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NSYS | ALGS |
|---|---|---|
| Founded | 1981 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.1M | 34.6M |
| IPO Year | 1996 | 2020 |
Fundamental Metrics
Financial Performance| Metric | NSYS | ALGS |
|---|---|---|
| Price | $11.42 | $5.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $39.33 |
| AVG Volume (30 Days) | 15.3K | ★ 47.8K |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 80.85 | ★ 88.30 |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $14,371,000.00 | $2,186,000.00 |
| Revenue This Year | N/A | $32.20 |
| Revenue Next Year | N/A | $4.71 |
| P/E Ratio | $124.78 | ★ N/A |
| Revenue Growth | ★ 7.01 | N/A |
| 52 Week Low | $6.50 | $3.98 |
| 52 Week High | $18.01 | $13.69 |
Technical Indicators
Market Signals| Indicator | NSYS | ALGS |
|---|---|---|
| Relative Strength Index (RSI) | 41.26 | 48.64 |
| Support Level | $11.23 | $4.81 |
| Resistance Level | $12.21 | $5.94 |
| Average True Range (ATR) | 0.47 | 0.46 |
| MACD | 0.07 | 0.02 |
| Stochastic Oscillator | 22.80 | 54.62 |
Price Performance
Historical ComparisonAbout NSYS Nortech Systems Incorporated
Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.